Bioinformatic analyses identifies novel protein-coding pharmacogenomic markers associated with paclitaxel sensitivity in NCI60 cancer cell lines
<p>Abstract</p> <p>Background</p> <p>Paclitaxel is a microtubule-stabilizing drug that has been commonly used in treating cancer. Due to genetic heterogeneity within patient populations, therapeutic response rates often vary. Here we used the NCI60 panel to identify SNP...
Saved in:
Main Authors: | Jarjanazi Hamdi (Author), Ibrahim-zada Irada (Author), Eng Lawson (Author), Savas Sevtap (Author), Meschian Mehran (Author), Pritchard Kathleen I (Author), Ozcelik Hilmi (Author) |
---|---|
Format: | Book |
Published: |
BMC,
2011-02-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Bioinformatics analysis to identify action targets in NCI-N87 gastric cancer cells exposed to quercetin
by: Yun Zeng, et al.
Published: (2018) -
Nuremberg code turns 60
by: Michel Thieren, et al.
Published: (2007) -
The NRF2-mediated oxidative stress response pathway is associated with tumor cell resistance to arsenic trioxide across the NCI-60 panel
by: Liu Qian, et al.
Published: (2010) -
Z60.5/(En)Coded
Published: (2023) -
7-Chloroquinolinehydrazones as First-in-Class Anticancer Experimental Drugs in the NCI-60 Screen among Different Investigated Series of Aryl, Quinoline, Pyridine, Benzothiazole and Imidazolehydrazones
by: Georgiana Negru (Apostol), et al.
Published: (2023)